Jinfan Li
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 3
- Ubiquitin and proteasome pathways 2
- Oncology 10
- Co-authors
- Shu Zheng (3 shared papers)Jiaojiao Zhou (2 shared papers)Danfeng Lin (1 shared paper)Lesang Shen (1 shared paper)Dan Zhou (1 shared paper)Yiding Chen (1 shared paper)Meng Luo (1 shared paper)Kun Zhang (1 shared paper)
- Journals
- Frontiers in Oncology (4 papers)Separation and Purification Technology (2 papers)Tumor Biology (2 papers)Cancer Letters (1 paper)Microchemical Journal (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Jinfan Li
43 papers receiving 1.5k citations
Jinfan Li's Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 330
- Oncology 420
- Filtration and Separation 17
- Molecular Biology 426
- Immunology 103
Countries citing papers authored by Jinfan Li
This map shows the geographic impact of Jinfan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinfan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinfan Li more than expected).
Fields of papers citing papers by Jinfan Li
This network shows the impact of papers produced by Jinfan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinfan Li. The network helps show where Jinfan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinfan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Circulating tumor cells: biology and clinical significance Hit paper breakdown → | 2021 | 676 |
| 2 | 2022 | 124 | |
| 3 | 2015 | 84 | |
| 4 | 2023 | 58 | |
| 5 | 2024 | 45 | |
| 6 | 2021 | 43 | |
| 7 | 2021 | 42 | |
| 8 | 2020 | 41 | |
| 9 | 2023 | 39 | |
| 10 | 2024 | 38 | |
| 11 | 2022 | 36 | |
| 12 | 2022 | 28 | |
| 13 | 2023 | 27 | |
| 14 | 2022 | 26 | |
| 15 | 2024 | 25 | |
| 16 | 2020 | 22 | |
| 17 | 2021 | 18 | |
| 18 | 2022 | 16 | |
| 19 | 2019 | 13 | |
| 20 | 2023 | 10 |
About Jinfan Li
Jinfan Li is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Mechanical Engineering and Electrical and Electronic Engineering, having authored 46 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Advancements in Battery Materials (4 papers), Metal-Organic Frameworks: Synthesis and Applications (3 papers), Covalent Organic Framework Applications (3 papers), Advanced Battery Materials and Technologies (3 papers), Gear and Bearing Dynamics Analysis (3 papers), RNA modifications and cancer (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Cancer Research (330 citations), Oncology (420 citations), Filtration and Separation (17 citations), Molecular Biology (426 citations) and Immunology (103 citations). Jinfan Li has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Shu Zheng, Jiaojiao Zhou, Danfeng Lin, Lesang Shen, Dan Zhou, Yiding Chen, Meng Luo, Kun Zhang, Qi Yang and Fangfang Zhu. Their work appears in journals such as Frontiers in Oncology, Separation and Purification Technology, Tumor Biology, Cancer Letters and Microchemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.